EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trials

A fraud conviction and seven-year prison sentence haven’t spared “Pharma Bro” and Wu-Tang Clan enthusiast Martin Shkreli from a federal antitrust lawsuit tied to his ...
13 December 2021 Regional News antitrust | Daraprim
Continue Reading →
Regional News

China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A

China unveiled new inclusions in its national reimbursement drug list, featuring novel therapies from Biogen, Pfizer, Eli Lilly and more. Partners Biocon and Viatris ...
13 December 2021 Regional News antibody drugs | ASLAN Pharmaceuticals
Continue Reading →
Regional News

Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe

For years, drugmakers have targeted "weaknesses" in the U.S. healthcare system to reap dividends on older meds, The House Oversight Committee said Friday. The "outra...
13 December 2021 Regional News diabetes | drug costs
Continue Reading →
Regional News

Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze

On the centennial of the discovery of insulin, China decided a round of price cuts on the diabetes therapy is due. As a result, foreign companies Novo Nordisk, Sanofi...
1 December 2021 Regional News china | drug prices
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte